UK Markets closed

Infinity Pharmaceuticals, Inc. (INFI)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.2900-0.1400 (-9.79%)
At close: 04:00PM EST
Currency in USD

Valuation measures4

We're sorry, we couldn't find any data.
Please try reloading the page.

Trading information

Stock price history

Beta (5Y monthly) 1.96
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 35.9800
52-week low 31.2900
50-day moving average 32.2346
200-day moving average 32.8533

Share statistics

Avg vol (3-month) 31.63M
Avg vol (10-day) 31.92M
Shares outstanding 589.02M
Implied shares outstanding 6N/A
Float 878.7M
% held by insiders 12.17%
% held by institutions 158.68%
Shares short (14 Dec 2021) 42.74M
Short ratio (14 Dec 2021) 41.43
Short % of float (14 Dec 2021) 43.14%
Short % of shares outstanding (14 Dec 2021) 43.07%
Shares short (prior month 14 Nov 2021) 42.21M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:4
Last split date 312 Sept 2006

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sept 2021

Profitability

Profit margin 0.00%
Operating margin (ttm)-2,377.43%

Management effectiveness

Return on assets (ttm)-38.68%
Return on equity (ttm)-490.76%

Income statement

Revenue (ttm)1.84M
Revenue per share (ttm)0.02
Quarterly revenue growth (yoy)-13.70%
Gross profit (ttm)-26.08M
EBITDA -43.34M
Net income avi to common (ttm)-44.21M
Diluted EPS (ttm)-0.5570
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)90.09M
Total cash per share (mrq)1.01
Total debt (mrq)1.6M
Total debt/equity (mrq)4.97
Current ratio (mrq)7.44
Book value per share (mrq)0.36

Cash flow statement

Operating cash flow (ttm)-39.41M
Levered free cash flow (ttm)-22.2M